Electroretinographic assessment in major depressed patients receiving duloxetine: Might differences between responders and non-responders indicate a differential biological background?

Michele Fornaro, Fabio Bandini, Carla Ogliastro, Christian Cordano, Matteo Martino, Luca Cestari, Andrea Escelsior, Giulio Rocchi, Salvatore Colicchio, Giulio Perugi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction: Despite intense research efforts, still too little is known about the biological determinants of depression, thus soliciting diverse study approaches. Among others, the electroretinography (ERG) has been proposed even as a putative proxy (retinal) measurement of central dopaminergic activity for Major Depressive Disorder (MDD) both in drug-naïve patients and subjects receiving antidepressant treatments. Nonetheless, current evidences are merely preliminary, essentially considering just older classes of antidepressants, thus requiring confirmation studies even with newer agents as duloxetine. Method: Twenty MDD subjects and 20 matched controls received duloxetine 60 mg/day for 12 weeks, being monitored both by standard ERG recording and by administration of the Hamilton scales for Depression and Anxiety and the Young Mania Rating Scale at baseline and week 12 (end of the study). Results: ERG mean rod b-wave amplitude significantly reduced from baseline to week 12 in those depressed subjects achieving final response (p =.024), decreasing from the highest rank values to the ones, substantially unmodified, seen among non-responders and controls. Limitations: Small sample size and lack of multiple assessments. Conclusions: At least some MDD patients responding to duloxetine might exhibit a peculiar ERG pattern, hypothetically indicating a specific biological background. If confirmed by larger-sampled studies, these results might shed further light in the understanding of the biological determinants of different subtypes of depression, ideally showing alternative patters of response upon different treatment interventions.

Original languageEnglish
Pages (from-to)154-159
Number of pages6
JournalJournal of Affective Disorders
Volume135
Issue number1-3
DOIs
Publication statusPublished - Dec 1 2011
Externally publishedYes

Fingerprint

Electroretinography
Major Depressive Disorder
Depression
Antidepressive Agents
Proxy
Bipolar Disorder
Sample Size
Anxiety
Duloxetine Hydrochloride
Therapeutics
Research
Pharmaceutical Preparations

Keywords

  • Duloxetine
  • Electroretinogram (ERG)
  • Major Depressive Disorder (MDD)

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Electroretinographic assessment in major depressed patients receiving duloxetine : Might differences between responders and non-responders indicate a differential biological background? / Fornaro, Michele; Bandini, Fabio; Ogliastro, Carla; Cordano, Christian; Martino, Matteo; Cestari, Luca; Escelsior, Andrea; Rocchi, Giulio; Colicchio, Salvatore; Perugi, Giulio.

In: Journal of Affective Disorders, Vol. 135, No. 1-3, 01.12.2011, p. 154-159.

Research output: Contribution to journalArticle

Fornaro, Michele ; Bandini, Fabio ; Ogliastro, Carla ; Cordano, Christian ; Martino, Matteo ; Cestari, Luca ; Escelsior, Andrea ; Rocchi, Giulio ; Colicchio, Salvatore ; Perugi, Giulio. / Electroretinographic assessment in major depressed patients receiving duloxetine : Might differences between responders and non-responders indicate a differential biological background?. In: Journal of Affective Disorders. 2011 ; Vol. 135, No. 1-3. pp. 154-159.
@article{66162d711cb84c22b21c54c273eb8f00,
title = "Electroretinographic assessment in major depressed patients receiving duloxetine: Might differences between responders and non-responders indicate a differential biological background?",
abstract = "Introduction: Despite intense research efforts, still too little is known about the biological determinants of depression, thus soliciting diverse study approaches. Among others, the electroretinography (ERG) has been proposed even as a putative proxy (retinal) measurement of central dopaminergic activity for Major Depressive Disorder (MDD) both in drug-na{\"i}ve patients and subjects receiving antidepressant treatments. Nonetheless, current evidences are merely preliminary, essentially considering just older classes of antidepressants, thus requiring confirmation studies even with newer agents as duloxetine. Method: Twenty MDD subjects and 20 matched controls received duloxetine 60 mg/day for 12 weeks, being monitored both by standard ERG recording and by administration of the Hamilton scales for Depression and Anxiety and the Young Mania Rating Scale at baseline and week 12 (end of the study). Results: ERG mean rod b-wave amplitude significantly reduced from baseline to week 12 in those depressed subjects achieving final response (p =.024), decreasing from the highest rank values to the ones, substantially unmodified, seen among non-responders and controls. Limitations: Small sample size and lack of multiple assessments. Conclusions: At least some MDD patients responding to duloxetine might exhibit a peculiar ERG pattern, hypothetically indicating a specific biological background. If confirmed by larger-sampled studies, these results might shed further light in the understanding of the biological determinants of different subtypes of depression, ideally showing alternative patters of response upon different treatment interventions.",
keywords = "Duloxetine, Electroretinogram (ERG), Major Depressive Disorder (MDD)",
author = "Michele Fornaro and Fabio Bandini and Carla Ogliastro and Christian Cordano and Matteo Martino and Luca Cestari and Andrea Escelsior and Giulio Rocchi and Salvatore Colicchio and Giulio Perugi",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.jad.2011.07.013",
language = "English",
volume = "135",
pages = "154--159",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Electroretinographic assessment in major depressed patients receiving duloxetine

T2 - Might differences between responders and non-responders indicate a differential biological background?

AU - Fornaro, Michele

AU - Bandini, Fabio

AU - Ogliastro, Carla

AU - Cordano, Christian

AU - Martino, Matteo

AU - Cestari, Luca

AU - Escelsior, Andrea

AU - Rocchi, Giulio

AU - Colicchio, Salvatore

AU - Perugi, Giulio

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Introduction: Despite intense research efforts, still too little is known about the biological determinants of depression, thus soliciting diverse study approaches. Among others, the electroretinography (ERG) has been proposed even as a putative proxy (retinal) measurement of central dopaminergic activity for Major Depressive Disorder (MDD) both in drug-naïve patients and subjects receiving antidepressant treatments. Nonetheless, current evidences are merely preliminary, essentially considering just older classes of antidepressants, thus requiring confirmation studies even with newer agents as duloxetine. Method: Twenty MDD subjects and 20 matched controls received duloxetine 60 mg/day for 12 weeks, being monitored both by standard ERG recording and by administration of the Hamilton scales for Depression and Anxiety and the Young Mania Rating Scale at baseline and week 12 (end of the study). Results: ERG mean rod b-wave amplitude significantly reduced from baseline to week 12 in those depressed subjects achieving final response (p =.024), decreasing from the highest rank values to the ones, substantially unmodified, seen among non-responders and controls. Limitations: Small sample size and lack of multiple assessments. Conclusions: At least some MDD patients responding to duloxetine might exhibit a peculiar ERG pattern, hypothetically indicating a specific biological background. If confirmed by larger-sampled studies, these results might shed further light in the understanding of the biological determinants of different subtypes of depression, ideally showing alternative patters of response upon different treatment interventions.

AB - Introduction: Despite intense research efforts, still too little is known about the biological determinants of depression, thus soliciting diverse study approaches. Among others, the electroretinography (ERG) has been proposed even as a putative proxy (retinal) measurement of central dopaminergic activity for Major Depressive Disorder (MDD) both in drug-naïve patients and subjects receiving antidepressant treatments. Nonetheless, current evidences are merely preliminary, essentially considering just older classes of antidepressants, thus requiring confirmation studies even with newer agents as duloxetine. Method: Twenty MDD subjects and 20 matched controls received duloxetine 60 mg/day for 12 weeks, being monitored both by standard ERG recording and by administration of the Hamilton scales for Depression and Anxiety and the Young Mania Rating Scale at baseline and week 12 (end of the study). Results: ERG mean rod b-wave amplitude significantly reduced from baseline to week 12 in those depressed subjects achieving final response (p =.024), decreasing from the highest rank values to the ones, substantially unmodified, seen among non-responders and controls. Limitations: Small sample size and lack of multiple assessments. Conclusions: At least some MDD patients responding to duloxetine might exhibit a peculiar ERG pattern, hypothetically indicating a specific biological background. If confirmed by larger-sampled studies, these results might shed further light in the understanding of the biological determinants of different subtypes of depression, ideally showing alternative patters of response upon different treatment interventions.

KW - Duloxetine

KW - Electroretinogram (ERG)

KW - Major Depressive Disorder (MDD)

UR - http://www.scopus.com/inward/record.url?scp=80055016483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055016483&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2011.07.013

DO - 10.1016/j.jad.2011.07.013

M3 - Article

C2 - 21820182

AN - SCOPUS:80055016483

VL - 135

SP - 154

EP - 159

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -